| safety and effectiveness of amphotericin b deoxycholate for the treatment of visceral leishmaniasis in uganda. | between september 2003 and april 2004, the supply of antimonial drugs to amudat hospital, in north-eastern uganda, was interrupted and all cases of visceral leishmaniasis presenting at the hospital could only be treated with amphotericin b deoxycholate (amb). this allowed the safety and effectiveness of the amb to be evaluated, in comparison with an historical cohort of patients treated, at the same hospital, with meglumine antimoniate (sb(v)). demographic and clinical data were collected before ... | 2008 | 18186974 |
| risk factors of visceral leishmaniasis in east africa: a case-control study in pokot territory of kenya and uganda. | in east africa, visceral leishmaniasis (vl) is endemic in parts of sudan, ethiopia, somalia, kenya and uganda. it is caused by leishmania donovani and transmitted by the sandfly vector phlebotomus martini. in the pokot focus, reaching from western kenya into eastern uganda, formulation of a prevention strategy has been hindered by the lack of knowledge on vl risk factors as well as by lack of support from health sector donors. the present study was conducted to establish the necessary evidence-b ... | 2008 | 18184669 |